FibroBiologics closes USD 0.5 million private placement with chief scientific officer
FBLG•Private placement closed with chief scientific officer
FibroBiologics closed a USD 0.5 million private placement with Chief Scientific Officer Hamid Khoja on Sept. 15, 2026.
- The company sold 298,508 common shares with warrants for up to 298,508 more shares at a combined USD 1.68 per share-warrant.
- The warrants are immediately exercisable at USD 1.55 per share and expire five years from issuance.
- Net proceeds are earmarked for general corporate purposes, including working capital.
